Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors
Molecules · 2024
DOI: 10.3390/molecules29215062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Lin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xinyang Agriculture and Forestry University, Xinyang 464000, China. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, 1-Deoxynojirimycin, Molecular Docking Simulation, alpha-Glucosidases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan, the Henan Science and Technology Program, Innovative Research Team of the Active Ingredients and Efficacy Correlation Evaluation System with Dabie Mountain Traditional Chinese Medicine in Xinyang Agric….
Abstract (Originalsprache)
1-deoxynojirimycin (DNJ) is a well-known α-glucosidase inhibitor. A series of phenyltriazole-deoxynojirimycin hybrids containing C4 and C6 (4 and 6 methylenes, respectively) linkers were synthesized. These novel compounds were assessed for preliminary glucosidase inhibition and cytotoxicity tests in vitro. Among them, compounds 12–14 and 16–20 (IC50: 105 ± 9–11 ± 1 μM) were more active than deoxynojirimycin (DNJ, IC50 = 155 ± 15 μM). The kinetics of enzyme inhibition measured by using Lineweaver–Burk plots indicated that compounds 18 and 19 were competitive inhibitors. In addition, a molecular docking study of α-glucosidase revealed that the interaction modes and the orientations of compound 18 and DNJ were clearly different. Furthermore, in tissue culture, HL60 cell compounds showed no cytotoxicity at low concentrations. When the concentration reached 50 µM, only compound 20 exhibited cytotoxicity. The structure–activity relationships exhibit that the length of the linker and the nature of 4-position substituents on the phenyl have a significant effect on the inhibitory potency of glucosidases and cytotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xinyang Agriculture and Forestry University, Xinyang 464000, China.
- Nanjing Institute for Food and Drug Control, Nanjing 211198, China.
Förderung
- Natural Science Foundation of Henan
- the Henan Science and Technology Program
- Innovative Research Team of the Active Ingredients and Efficacy Correlation Evaluation System with Dabie Mountain Traditional Chinese Medicine in Xinyang Agric…
- Xinyang Agriculture and Forestry University Youth Fund Project
- Xinyang Agriculture and Forestry University National Research Project Cultivation Fund Project
- Henan Science and Technology Program
Zitieren
APA
Wang, L., Luo, W., Zhao, Y., Guo, X., Bai, X., Guo, L., & Zhu, N. (2024). Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors. Molecules. https://doi.org/10.3390/molecules29215062
Vancouver
Wang L, Luo W, Zhao Y, Guo X, Bai X, Guo L, et al. Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors. Molecules. 2024. doi:10.3390/molecules29215062
BibTeX
@article{Wang2024,
author = {Wang, Lin and Luo, Wei and Zhao, Yonghong and Guo, Xinling and Bai, Xiangru and Guo, Leilei and Zhu, Nailiang},
title = {Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29215062}
}
EUVIMED